Chirurgie bariatrique, lithiase oxalo-calcique et insuffisance rénale par néphropathie oxalique

Montagnac, R; Schendel, Adeline; Vuiblet, Vincent; Peilleron, Bruno; Piot, Olivier

doi:10.1016/j.nephro.2010.10.009

Cited by 5 publications

(3 citation statements)

References 66 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 14,160 potentially relevant citations were identified and screened; 430 titles and abstracts were screened using the inclusion and exclusion criteria; 147 were excluded on the basis of the title and abstract review; and 283 articles were retrieved for detailed evaluation, of which 67 fulfilled the eligibility criteria, which involved 108 patients ( Figure 1 ). 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , …”

Section: Resultsmentioning

confidence: 99%

“…All patients received hydration and dietary interventions, including the adoption of a normal calcium, low-oxalate diet. In addition, the use of diuretics for fluid overload, 15 , 46 , 70 alkali therapy to alkalinize the urine, 10 , 19 , 46 , 53 and pyridoxine to convert glyoxalate (the main precursor of oxalate) to glycine 15 , 19 , 44 , 48 , 65 , 70 was variably reported and had inconsistent impact on recovery of kidney function ( Supplemental Table S1 ).…”

Section: Resultsmentioning

confidence: 99%

“…According to the European Primary Hyperoxaluria Registry, the 5-year survival rate of patients with primary hyperoxaluria is 76%, possibly due to a younger age at onset. 104 Hydration, 3 , 8 , 13 , 19 , 28 , 46 , 47 , 60 , 62 , 63 , 68 alkali therapy, 19 , 46 and pyridoxine 19 , 44 , 48 , 70 for treatment of oxalate nephropathy has yielded unsatisfactory results. Treatment of oxalate nephropathy in patients with native kidneys and kidney allografts likely depends on the underlying etiology, but low-oxalate and low-fat diets are generally recommended.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Secondary Oxalate Nephropathy: A Systematic Review

Lumlertgul

Siribamrungwong

Jaber

et al. 2018

Kidney International Reports

View full text Add to dashboard Cite

IntroductionLittle is known of the clinical outcomes of secondary oxalate nephropathy. To inform clinical practice, we performed a systematic review of case reports and case series to examine the clinical characteristics and outcomes of patients with secondary oxalate nephropathy.MethodsElectronic databases were searched for case reports and case series of individual cases or cohorts of patients with biopsy-proven oxalate nephropathy in native or transplanted kidneys from 1950 until January 2018.ResultsFifty-seven case reports and 10 case series met the inclusion criteria, totaling 108 patients. The case series were meta-analyzed. Mean age was 56.4 years old, 59% were men, and 15% were kidney transplant recipients. Fat malabsorption (88%) was the most commonly attributed cause of oxalate nephropathy, followed by excessive dietary oxalate consumption (20%). The mean baseline serum creatinine was 1.3 mg/dl and peaked at 4.6 mg/dl. Proteinuria, hematuria, and urinary crystals was reported in 69%, 32%, and 26% of patients, respectively. Mean 24-hour urinary oxalate excretion was 85.4 mg/d. In addition to universal oxalate crystal deposition in tubules and/or interstitium, kidney biopsy findings included acute tubular injury (71%), tubular damage and atrophy (69%), and interstitial mononuclear cell infiltration (72%); 55% of patients required dialysis. None had complete recovery, 42% had partial recovery, and 58% remained dialysis-dependent. Thirty-three percent of patients died.ConclusionSecondary oxalate nephropathy is a rare but potentially devastating condition. Renal replacement therapy is required in >50% of patients, and most patients remain dialysis-dependent. Studies are needed for effective preventive and treatment strategies in high-risk patients with hyperoxaluria-enabling conditions.

show abstract